AMGEN INC 10-Q filing
Filed 2026-05-01 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0000318154-26-000057
- Form type
- 10-Q
- CIK
- 0000318154
- Primary document
- https://www.sec.gov/Archives/edgar/data/318154/000031815426000057/amgn-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AMGEN INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $8.6B | - | - |
| Cost Of Revenue | $2.7B | - | - |
| Operating Income | $2.7B | - | - |
| Net Income | $1.8B | - | - |
| Eps Basic | 3.37 | - | - |
| Eps Diluted | 3.34 | - | - |
| Cash And Equivalents | $12.0B | - | - |
| Total Assets | $92.5B | - | - |
| Shareholders Equity | $9.2B | - | - |
| Operating Cash Flow | $2.2B | - | - |
| Capital Expenditures | $712.0M | - | - |